Organogenesis Holdings Inc. - Class A Common Stock, par value $0.0001 per share (ORGO)

Historical Holders from Q4 2018 to Q3 2025

Symbol
ORGO on Nasdaq
Type / Class
Equity / Class A Common Stock, par value $0.0001 per share
Shares outstanding
126,273,814
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
68,404,092
Holdings value
$288,621,037
% of all portfolios
0.001%
Number of holders
118
Number of buys
49
Number of sells
-61
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Organogenesis Holdings Inc. - Class A Common Stock, par value $0.0001 per share (ORGO)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Ades Alan A. 17.6% -1.1% $66,289,913 22,319,836 0% Alan A. Ades 24 Jun 2025
Soleus Capital Master Fund, L.P. 9.9% $58,304,371 12,484,876 Soleus Capital Master Fund, L.P. 31 Dec 2024
NUSSDORF GLENN H 9.7% $51,688,923 12,248,560 Glenn H. Nussdorf 14 May 2025
First Light Asset Management, LLC 6.55% $35,730,437 8,309,404 Mathew P. Arens 30 Jun 2025

Institutional Holders of Organogenesis Holdings Inc. - Class A Common Stock, par value $0.0001 per share (ORGO)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 68,404,092 $288,621,037 -$3,810,608 $4.22 118
2025 Q2 69,383,599 $253,970,094 +$15,169,482 $3.66 113
2025 Q1 64,527,988 $278,764,897 +$10,290,470 $4.32 135
2024 Q4 62,559,435 $200,195,689 -$4,632,565 $3.2 119
2024 Q3 63,992,032 $183,024,939 +$3,073,151 $2.86 111
2024 Q2 62,887,604 $176,087,539 +$15,313,422 $2.8 114
2024 Q1 57,059,906 $162,044,497 -$4,218,961 $2.84 123
2023 Q4 58,271,447 $238,328,151 +$24,483,565 $4.09 107
2023 Q3 52,567,125 $167,155,866 +$2,434,079 $3.18 103
2023 Q2 51,683,797 $171,584,944 -$2,458,393 $3.32 111
2023 Q1 53,442,433 $113,798,804 -$5,356,219 $2.13 130
2022 Q4 56,005,330 $150,650,419 +$1,931,028 $2.69 146
2022 Q3 55,031,412 $178,300,322 -$19,442,671 $3.24 144
2022 Q2 58,051,832 $283,327,408 -$3,172,672 $4.88 140
2022 Q1 57,887,989 $440,942,195 +$10,319,977 $7.62 147
2021 Q4 55,836,563 $515,731,659 -$2,571,363 $9.24 151
2021 Q3 53,370,851 $762,477,663 +$42,467,188 $14.24 141
2021 Q2 49,939,204 $830,012,497 +$410,032,084 $16.62 140
2021 Q1 24,855,592 $453,129,001 +$68,036,540 $18.22 99
2020 Q4 21,338,757 $160,687,218 +$122,816,812 $7.53 65
2020 Q3 4,977,699 $19,103,728 +$2,285,403 $3.84 47
2020 Q2 4,380,098 $16,755,945 +$2,234,312 $3.84 47
2020 Q1 3,847,640 $12,393,195 -$1,227,774 $3.23 50
2019 Q4 4,058,177 $19,521,798 +$10,098,739 $4.81 53
2019 Q3 1,894,140 $12,445,423 +$1,959,070 $6.57 37
2019 Q2 1,463,592 $11,124,205 +$4,972,528 $7.6 27
2019 Q1 812,507 $6,092,000 +$6,092,000 $7.5 16
2018 Q4 $10.15 0